| アブストラクト | Clozapine-induced gastrointestinal hypomotility (CIGH) is poorly understood and potentially life-threatening. Herein, we present trends of CIGH annual reporting and explore factors associated with a fatal outcome using 25-years of pharmacovigilance data in Canada. Since 1993, the number of CIGH reports increased 22-fold but the proportion of fatal reports remained relatively stable. Fatal reports of CIGH were associated with older age but not sex, clozapine dose, or clozapine duration. Concomitant use of medications used to treat CIGH (lactulose, docusate sodium) and its associated pain/discomfort (acetaminophen, lorazepam) were more commonly reported in fatal cases. Confirmatory and prospective studies of CIGH are warranted. |
|---|
| 組織名 | Alberta Innovates Heritage Youth Researcher Summer Program, University of;Calgary, Calgary, AB, Canada.;Mathison Centre for Mental Health Research & Education, Hotchkiss Brain;Institute, Cumming School of Medicine, University of Calgary, Calgary, AB,;Canada; Department of Psychiatry, University of Calgary, Calgary, AB, Canada;;Department of Physiology & Pharmacology, University of Calgary, Calgary, AB,;Canada.;Canada; Department of Medical Genetics, University of Calgary, Calgary, AB,;Canada; Alberta Children's Hospital Research Institute, University of Calgary,;Calgary, AB, Canada. Electronic address: chad.bousman@ucalagary.ca. |
|---|
